ESMFold vs AlphaFold2: Protein Structure Prediction Compared

Protein structure prediction has been transformed by AI. Two models dominate the field: AlphaFold2 (Jumper et al., Nature 2021) and

ESMFold (Lin et al., Science 2023). Both predict 3D protein structures from amino acid sequences, but they differ in fundamental ways that matter for drug discovery workflows.

How They Work#

AlphaFold2: MSA-Based Prediction#

AlphaFold2 uses multiple sequence alignments (MSAs) — evolutionary information from related proteins across species — to predict structure. The model searches sequence databases (UniRef, BFD, MGnify) to find homologous sequences, then uses the co-evolutionary signal to infer residue contacts and predict 3D coordinates.

• Input: Amino acid sequence + MSA generation (minutes to hours)
• Architecture: Evoformer + structure module with iterative recycling
• Published accuracy: Median GDT-TS of 92.4 on CASP14 (Jumper et al., 2021)
• Key strength: Highest accuracy, especially for proteins with rich evolutionary data

ESMFold: Single-Sequence Prediction#

ESMFold uses a protein language model (ESM-2) trained on 65 million protein sequences (Lin et al., 2023). Instead of searching for homologs, it extracts structural information directly from the learned representations of a single input sequence.

• Input: Amino acid sequence only — no MSA required
• Architecture: ESM-2 language model + folding trunk
• Published accuracy: Median GDT-TS of 87.0 on CASP14 (Lin et al., 2023)
• Key strength: about 60x faster than AlphaFold2 on a single GPU with no MSA search — seconds per structure vs minutes

Accuracy Comparison#

On the CASP14 benchmark (the standard evaluation for protein structure prediction):

ESMFold achieves near-AlphaFold accuracy for many protein families, particularly those with well-studied folds. The accuracy gap widens for novel folds and multi-domain proteins where evolutionary co-variation data provides critical long-range contact information.

When to Use Each#

Use ESMFold when:#

• Speed matters: Screening hundreds or thousands of protein sequences (e.g., metagenomic datasets). ESMFold predicted 617 million metagenomic protein structures in the ESM Metagenomic Atlas (Lin et al., 2023).
• No homologs exist: Orphan proteins, de novo designed proteins, or heavily engineered sequences where MSA provides little signal.
• Early-stage triage: Quick structural assessment before committing to more expensive analyses.
• Iterative design: Rapid structure checks during protein engineering cycles.

Use AlphaFold2 when:#

• Maximum accuracy is critical: Lead candidate structures for docking campaigns, where even 1-2 Angstrom differences affect binding pose predictions.
• Multi-domain proteins: Complex architectures where long-range evolutionary contacts are essential.
• Publication-grade results: When the structure will be the primary basis for experimental design or publication.

Practical Workflow on Ivy Biosciences#

On the .bloom* platform, both models are available as one-click tools:

1. Start with ESMFold for rapid screening — submit a FASTA sequence and get a PDB structure in seconds
2. Inspect the pLDDT score — ESMFold's per-residue confidence score. Regions above 70 are generally reliable; below 50 suggests disorder or uncertainty
3. Follow up with AlphaFold2 for your top candidates if ESMFold confidence is borderline or if you need higher accuracy for docking
4. Chain into docking — pipe the predicted structure directly into DiffDock for binding pose prediction, then rescore the poses with MM-GBSA

Both tools output standard PDB files with pLDDT B-factor annotation, compatible with molecular viewers like Mol*, PyMOL, and ChimeraX.

Beyond AlphaFold2 and ESMFold#

The protein structure prediction landscape continues to evolve:

• ESM3 (Hayes et al., bioRxiv 2024) extends ESMFold with multimodal capabilities — generating sequences, structures, and functional annotations simultaneously
• AlphaFold3 (Abramson et al., Nature 2024) predicts complexes of proteins with DNA, RNA, ligands, and post-translational modifications
• OpenFold (Ahdritz et al., bioRxiv 2022) provides an open-source reimplementation of AlphaFold2 with training code

Key Takeaways#

• ESMFold is about 60x faster than AlphaFold2 on a single GPU and requires no MSA, making it ideal for high-throughput screening
• AlphaFold2 remains more accurate (median GDT-TS 92.4 vs 87.0), especially for multi-domain proteins
• For drug discovery, a two-stage workflow — ESMFold for triage, AlphaFold2 for refinement — balances speed and accuracy
• Both models are freely available on the Ivy Biosciences platform with GPU acceleration

The best choice depends on your specific use case. For most drug discovery workflows, starting with ESMFold and escalating to AlphaFold2 for top candidates gives you the best of both worlds.

References#

1. Jumper, J., Evans, R., Pritzel, A. et al. "Highly accurate protein structure prediction with AlphaFold." Nature 596, 583–589 (2021). doi:10.1038/s41586-021-03819-2
2. Lin, Z., Akin, H., Rao, R. et al. "Evolutionary-scale prediction of atomic-level protein structure with a language model." Science 379, 1123–1130 (2023). doi:10.1126/science.ade2574
3. Hayes, T., Rao, R., Akin, H. et al. "Simulating 500 million years of evolution with a language model." bioRxiv (2024). doi:10.1101/2024.07.01.600583
4. Abramson, J., Adler, J., Dunger, J. et al. "Accurate structure prediction of biomolecular interactions with AlphaFold 3." Nature 630, 493–500 (2024). doi:10.1038/s41586-024-07487-w